NASDAQ:HYFT

MindWalk Q3 2026 Earnings Results & Report

MindWalk logo
$0.80 -0.10 (-11.11%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$0.80 +0.00 (+0.38%)
As of 11/19/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MindWalk missed analyst expectations on both earnings and revenue in its Q3 2026 results, released March 12, 2026. The company reported EPS of -$0.06 versus the -$0.04 consensus estimate, while revenue of $3 million fell short of the $3.50 million estimate by $500 thousand.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
Before Market Opens

MindWalk EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.04
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

MindWalk Revenue Results

Actual Revenue
$3 million
Expected Revenue
$3.50 million
Beat/Miss
Missed by -$500.00 thousand
YoY Revenue Growth
N/A

Conference Call Resources

MindWalk Q3 2026 Earnings FAQ

MindWalk (NASDAQ:HYFT) reported earnings of -$0.06 per share for Q3 2026, missing the consensus estimate of -$0.04. The report was announced on Thursday, March 12, 2026.

MindWalk reported revenue of $3 million for Q3 2026, against a consensus estimate of $3.50 million.

MindWalk Earnings Headlines

Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
Why the Next Edge in Antibody Discovery May Be What Labs Remember
See More MindWalk Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MindWalk? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MindWalk and other key companies, straight to your email.

About MindWalk

MindWalk (NASDAQ:HYFT) is a biotechnology and computational biology company focused on using artificial intelligence and data analysis to support biological research and drug discovery.

The company’s proprietary Hyft technology is designed to identify patterns in biological data, including genomic and other biomolecular information. MindWalk positions its platform as a tool for researchers and life-sciences organizations seeking insights that can inform therapeutic research and development.

View MindWalk Profile